128 related articles for article (PubMed ID: 3264035)
1. Single photon emission computed tomography (SPECT) in a patient with Wilson's disease.
Komine Y; Shundo F; Shirahata N; Takahashi K; Fujita T
Jpn J Med; 1988 Aug; 27(3):309-10. PubMed ID: 3264035
[TBL] [Abstract][Full Text] [Related]
2. [Short interval change of 99mTc-ethyl cysteinate dimer single photon emission computed tomography in Wilson's disease].
Imai N; Nozaki H; Miyata K; Terayama Y; Ishihara N
No To Shinkei; 1999 Sep; 51(9):785-9. PubMed ID: 10511956
[TBL] [Abstract][Full Text] [Related]
3. Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.
Oertel WH; Tatsch K; Schwarz J; Kraft E; Trenkwalder C; Scherer J; Weinzierl M; Vogl T; Kirsch CM
Ann Neurol; 1992 Dec; 32(6):743-8. PubMed ID: 1471864
[TBL] [Abstract][Full Text] [Related]
4. Initial clinical experiences with dopamine D2 receptor imaging by means of 2'-iodospiperone and single-photon emission computed tomography.
Yonekura Y; Saji H; Iwasaki Y; Tsuchida T; Fukuyama H; Shimatsu A; Iida Y; Magata Y; Konishi J; Yokoyama A
Ann Nucl Med; 1995 Aug; 9(3):131-6. PubMed ID: 8534585
[TBL] [Abstract][Full Text] [Related]
5. PET imaging of the basal ganglia.
Laihinen A; Halsband U
J Physiol Paris; 2006 Jun; 99(4-6):406-13. PubMed ID: 16723212
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography in hepatolenticular degeneration (Wilson's disease).
Chen XR; Shen TZ; Li NZ; Liu DK
Comput Radiol; 1983; 7(6):361-4. PubMed ID: 6641205
[TBL] [Abstract][Full Text] [Related]
7. Recovery of neurological deficits in a case of Wilson's disease after liver transplantation.
Lui CC; Chen CL; Cheng YF; Lee TY
Transplant Proc; 1998 Nov; 30(7):3324-5. PubMed ID: 9838469
[No Abstract] [Full Text] [Related]
8. [Epidural anesthesia and analgesia in a patient with cerebral manifestations of Wilson's disease].
Cuello Azcarate JJ; García Hernández E; González Rodríguez JL
Rev Esp Anestesiol Reanim; 2005 Oct; 52(8):505-6. PubMed ID: 16281749
[No Abstract] [Full Text] [Related]
9. Comparative study of regional cerebral blood flow values measured by Xe CT and Xe SPECT.
Matsuda M; Lee H; Kuribayashi K; Yoshimura M; Honda T; Handa J
Acta Neurol Scand Suppl; 1996; 166():13-6. PubMed ID: 8686428
[TBL] [Abstract][Full Text] [Related]
10. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
[TBL] [Abstract][Full Text] [Related]
11. [Regional cerebral blood flow in the acute stage with ischemic cerebrovascular disease studied by xenon-133 inhalation and single photon emission computerized tomography].
Kurokawa H; Iino K; Kojima H; Saito H; Suzuki M; Watanabe K; Kato T
No To Shinkei; 1987 May; 39(5):437-46. PubMed ID: 3497656
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.
Jeon B; Kim JM; Jeong JM; Kim KM; Chang YS; Lee DS; Lee MC
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):60-4. PubMed ID: 9667562
[TBL] [Abstract][Full Text] [Related]
13. Wilson's disease. Clinical correction with cranial computed tomography.
Kendall BE; Pollock SS; Bass NM; Valentine AR
Neuroradiology; 1981; 22(1):1-5. PubMed ID: 7301096
[TBL] [Abstract][Full Text] [Related]
14. Extensive CT scan abnormality in Wilson's disease.
Saha P; Jain S; Mishra NK; Khosla A; Maheshwari MC
J Assoc Physicians India; 1991 Jul; 39(7):568-9. PubMed ID: 1800506
[TBL] [Abstract][Full Text] [Related]
15. [Regional cerebral blood flow of the basal ganglia and thalamus measured using Xe-CT].
Haku T; Hosoya T; Komatani A; Honma T; Sugai Y; Adachi M; Yamaguchi K
No To Shinkei; 2000 Mar; 52(3):231-5. PubMed ID: 10769843
[TBL] [Abstract][Full Text] [Related]
16. Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy.
Ishida S; Doi Y; Yamane K; Sugino M; Kimura F; Hanafusa T; Fukui H; Tamai H
Intern Med; 2012; 51(13):1759-63. PubMed ID: 22790141
[TBL] [Abstract][Full Text] [Related]
17. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.
Rubin RT; Villanueva-Meyer J; Ananth J; Trajmar PG; Mena I
Arch Gen Psychiatry; 1992 Sep; 49(9):695-702. PubMed ID: 1514874
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.
Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A
Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413
[TBL] [Abstract][Full Text] [Related]
19. [Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
Bettin S; Kämpfer I; Seese A; Schäfer A; Reuter M; Lössner J; Dietrich J; Wagner A; Knapp WH
Nuklearmedizin; 1997 Aug; 36(5):167-72. PubMed ID: 9380528
[TBL] [Abstract][Full Text] [Related]
20. Critical cerebral blood flow thresholds studied by SPECT using xenon-133 and iodine-123 iodoamphetamine.
Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
J Nucl Med; 1989 Mar; 30(3):337-42. PubMed ID: 2786938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
